SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Auro Laboratories zooms on getting WHO-GMP certificate for Tarapur API facility

13 Nov 2025 Evaluate

Auro Laboratories is currently trading at Rs 195.90, up by 13.05 points or 7.14% from its previous closing of Rs 182.85 on the BSE.

The scrip opened at Rs 195.00 and has touched a high and low of Rs 199.00 and Rs 189.40 respectively. So far 3455 shares were traded on the counter.

The BSE group 'X' stock of face value Rs 10 has touched a 52-week high of Rs 303.00 on 17-Jul-2025 and a 52-week low of Rs 159.00 on 12-Nov-2025.

Last one week high and low of the scrip stood at Rs 200.00 and Rs 159.00 respectively. The current market cap of the company is Rs 118.48 crore.

The promoters holding in the company stood at 52.18%, while Institutions and Non-Institutions held 0.01% and 47.82% respectively.

Auro Laboratories has received World Health Organization-Good Manufacturing Practices (WHO - GMP) certificate from the Food & Drug Administration, Maharashtra, for its Active Pharmaceutical Ingredients (API) (Bulk Drugs) manufacturing located in MIDC Tarapur, Maharashtra. The certificate is valid up to September 30, 2028.

The company has received this certificate after it successfully completed WHO inspection at its API Tarapur manufacturing facility. 

Auro Laboratories is a manufacturer of Active Pharmaceutical Ingredients (APIs), Intermediates and Generic Formulations.

Auro Laboratories Share Price

269.70 6.00 (2.28%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×